Key result
Compared with wild-type mice, AMPK-DN mice demonstrated a prolonged time delay before microvascular PO2 began to decline during 1 Hz contractions (6.5 ± 0.4 s vs 3.2 ± 0.5 s; P<0.05).
Why the study?
Does muscle-specific AMPK dominant-negative mutation alter microvascular PO2 kinetics following the onset of muscle contractions in mice?
Does muscle-specific AMPK dominant-negative mutation alter microvascular PO2 kinetics following the onset of muscle contractions in mice?
Muscle-specific AMPK dominant-negative mutation in mice prolongs the time delay and shortens the time constant of microvascular PO2 decline at the onset of muscle contractions, indicating mitochondrial and microvascular dysfunction.
Answers are grounded in this paper and cite their sources.
Does not inform clinical practice; extends evidence for AMPK regulation of microvascular PO2 kinetics in murine muscle.
The microvascular partial pressure of oxygen (Pmv(o(2))) kinetics following the onset of exercise reflects the relationship between muscle O(2) delivery and uptake (Vo(2)). Although AMP-activated protein kinase (AMPK) is known as a regulator of mitochondria and nitric oxide metabolism, it is unclear whether the dynamic balance of O(2) delivery and Vo(2) at exercise onset is dependent on AMPK activation level. We used transgenic mice with muscle-specific AMPK dominant-negative (AMPK-DN) to investigate a role for skeletal muscle AMPK on Pmv(o(2)) kinetics following onset of muscle contractions. Phosphorescence quenching techniques were used to measure Pmv(o(2)) at rest and across the transition to twitch (1 Hz) and tetanic (100 Hz, 3-5 V, 4-ms pulse duration, stimulus duration of 100 ms every 1 s for 1 min) contractions in gastrocnemius muscles (each group n = 6) of AMPK-DN mice and wild-type littermates (WT) under isoflurane anesthesia with 100% inspired O(2) to avoid hypoxemia. Baseline Pmv(o(2)) before contractions was not different between groups (P > 0.05). Both muscle contraction conditions exhibited a delay followed by an exponential decrease in Pmv(o(2)). However, compared with WT, AMPK-DN demonstrated 1) prolongation of the time delay before Pmv(o(2)) began to decline (1 Hz: WT, 3.2 ± 0.5 s; AMPK-DN, 6.5 ± 0.4 s; 100 Hz: WT, 4.4 ± 1.0 s; AMPK-DN, 6.5 ± 1.4 s; P < 0.05), 2) a faster response time (i.e., time constant; 1 Hz: WT, 19.4 ± 3.9 s; AMPK-DN, 12.4 ± 2.6 s; 100 Hz: WT, 15.1 ± 2.2 s; AMPK-DN, 9.0 ± 1.7 s; P < 0.05). These findings are consistent with the presence of substantial mitochondrial and microvascular dysfunction in AMPK-DN mice, which likely slows O(2) consumption kinetics (i.e., oxidative phosphorylation response) and impairs the hyperemic response at the onset of contractions thereby sowing the seeds for exercise intolerance.
No takes yet. Share an insight, caveat, or question.
Kano et al. (2011) studied this question. Muscle-specific AMPK dominant-negative (AMPK-DN) mutation vs. Wild-type littermates (WT) was evaluated on Time delay before microvascular partial pressure of oxygen began to decline during 1 Hz contractions (p=<0.05). Compared with wild-type mice, AMPK-DN mice demonstrated a prolonged time delay before microvascular PO2 began to decline during 1 Hz contractions (6.5 ± 0.4 s vs 3.2 ± 0.5 s; P<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: